By contrast, Aw et al
Switching : does a patient switch molecule, dose, brand, or channel because of price, tolerability, supply, or clinical response
George, Cedar City, and Salt Lake City, Utah ), we focus on preventing telogen effluvium before it starts by supporting healthy, sustainable weight loss: Reviewing calorie and protein intake to avoid under-fueling Adjusting GLP-1 dosing and pacing to prevent crash physiology Identifying patients at higher risk for nutrient-related shedding (very low intake, heavy menstrual bleeding, prior bariatric surgery, restrictive diets) Using targeted lab testing only when clinically indicated to identify correctable deficiencies Providing nutrition and side-effect guidance so weight loss stays steady, not extreme Bottom line Hair shedding during Wegovy or Zepbound treatment is not a drug side effect it is usually a sign that weight loss or nutrition has become too aggressive for the body
This report presents finding from the first part of the research an on-site survey of Downtown West Palm Beach visitors